ArticleEClinicalMedicine2025

A head-to-head comparison of sextant-systematic biopsy vs. extended-systematic biopsy for prostate cancer diagnosis in the era of MRI-targeted biopsy: SEXTANT-PRO non-inferiority randomized clinical trial.

Ruiyi Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.